When engineering a contamination-controlled facility—whether for sterile pharmaceutical manufacturing, semiconductor microfabrication, medical device packaging, or biotechnology research—architectural specification decisions carry severe operational and financial consequences. Facility directors and project managers frequently evaluate whether standard commercial architectural doors can suffice or if dedicated clean room door assemblies are mandatory.
We manufacture these doors and their hardware on our own production lines, and the distinction matters more than most quotations admit. Table of Contents